Literature DB >> 19095987

LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study.

Tsuyoshi Imamura1, Yasufumi Doi, Hisatomi Arima, Koji Yonemoto, Jun Hata, Michiaki Kubo, Yumihiro Tanizaki, Setsuro Ibayashi, Mitsuo Iida, Yutaka Kiyohara.   

Abstract

BACKGROUND AND
PURPOSE: Although the relation between serum LDL cholesterol level and coronary heart disease (CHD) is well established, its relation with stroke subtypes is less clear.
METHODS: A total of 2351 inhabitants age >or=40 years in a Japanese community were followed up for 19 years.
RESULTS: During follow-up, 271 subjects developed stroke and 144 developed CHD. Whereas the age- and sex-adjusted incidences of CHD significantly increased with increasing LDL cholesterol levels (P for trend <0.001), the associations between LDL cholesterol level and the incidences of ischemic or hemorrhagic stroke were not significant. The age- and sex-adjusted incidences of atherothrombotic infarctions (ATIs) and lacunar infarctions (LIs) significantly increased with increasing LDL cholesterol level (P for trend=0.03 for ATIs and=0.02 for LIs), but no such association was observed for cardioembolic infarction. After multivariate adjustment, the positive associations of LDL cholesterol level with the risks of ATI and CHD remained significant (P for trend=0.02 for ATIs and=0.03 for CHD), whereas the association with LIs was not significant. The risk of ATI significantly increased in the fourth quartile of LDL cholesterol compared with the first quartile (multivariate-adjusted hazard ratio=2.84; 95% CI, 1.17 to 6.93). The multivariate-adjusted risks for developing nonembolic infarction (ATIs and LIs) and CHD were significantly elevated in the groups with elevated LDL cholesterol values with and without the metabolic syndrome.
CONCLUSIONS: Our findings suggest that an elevated LDL cholesterol level is a significant risk factor for developing ATI as well as CHD, and these associations are independent of the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095987     DOI: 10.1161/STROKEAHA.108.529537

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  49 in total

Review 1.  Epidemiology and prevention of stroke: a worldwide perspective.

Authors:  Elena V Kuklina; Xin Tong; Mary G George; Pooja Bansil
Journal:  Expert Rev Neurother       Date:  2012-02       Impact factor: 4.618

2.  A study of serum apolipoprotein A1, apolipoprotein B and lipid profile in stroke.

Authors:  Shilpasree As; Savitri Sahukar; Jayaprakash Murthy; Kiran Kumar
Journal:  J Clin Diagn Res       Date:  2013-07-01

3.  Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.

Authors:  Edward K Duran; Aaron W Aday; Nancy R Cook; Julie E Buring; Paul M Ridker; Aruna D Pradhan
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

4.  Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment.

Authors:  Hideki Wada; Manabu Ogita; Katsumi Miyauchi; Jun Shitara; Hirohisa Endo; Shinichiro Doi; Ryo Naito; Hirokazu Konishi; Shuta Tsuboi; Tomotaka Dohi; Takatoshi Kasai; Hiroshi Tamura; Shinya Okazaki; Kikuo Isoda; Satoru Suwa; Hiroyuki Daida
Journal:  Heart Vessels       Date:  2016-04-23       Impact factor: 2.037

Review 5.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

6.  Variations in the eicosapentaenoic acid-arachidonic acid ratio associated with age in acute myocardial infarction patients undergoing primary percutaneous coronary intervention.

Authors:  Keisuke Nakabayashi; Kentaro Jujo; Yuho Furuki; Issei Ishida; Hiroshi Ando; Minoru Shimizu; Nobuhisa Hagiwara; Katsumi Saito
Journal:  Heart Vessels       Date:  2018-11-14       Impact factor: 2.037

7.  Lipid Control and Beyond: Current and Future Indications for Statin Therapy in Stroke.

Authors:  Shadi Yaghi; Mitchell S V Elkind
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-04

8.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

Review 9.  Blood lipids and stroke: what more can we do besides reducing low-density lipoprotein cholesterol?

Authors:  Dominique Deplanque; Pierre Amarenco
Journal:  Curr Atheroscler Rep       Date:  2011-08       Impact factor: 5.113

10.  Risk Factors, Clinical Features and Prognosis for Subtypes of Ischemic Stroke in a Chinese Population.

Authors:  Ya-Fu Tan; Li-Xuan Zhan; Xiao-Hui Chen; Jian-Jun Guo; Chao Qin; En Xu
Journal:  Curr Med Sci       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.